Macquarie Group LTD Regeneron Pharmaceuticals, Inc. Transaction History

Macquarie Group LTD

  • $90.3 Billion
  • Q3 2024

A detailed history of Macquarie Group LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 75,141 shares of REGN stock, worth $53.7 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
75,141
Previous 76,425 1.68%
Holding current value
$53.7 Million
Previous $80.3 Million 1.66%
% of portfolio
0.09%
Previous 0.09%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$1024.09 - $1201.76 $1.31 Million - $1.54 Million
-1,284 Reduced 1.68%
75,141 $79 Million
Q2 2024

Aug 09, 2024
SELL
$883.2 - $1071.19 $373,593 - $453,113
-423 Reduced 0.55%
76,425 $80.3 Million
Q1 2024

May 14, 2024
SELL
$902.69 - $993.35 $1.71 Million - $1.88 Million
-1,890 Reduced 2.4%
76,848 $74 Million
Q4 2023

Feb 14, 2024
SELL
$775.18 - $881.7 $17.8 Million - $20.3 Million
-23,013 Reduced 22.62%
78,738 $69.2 Million
Q3 2023

Nov 14, 2023
BUY
$692.45 - $844.37 $344,840 - $420,496
498 Added 0.49%
101,751 $83.7 Million
Q2 2023

Aug 14, 2023
SELL
$700.03 - $830.35 $48.9 Million - $58 Million
-69,846 Reduced 40.82%
101,253 $72.8 Million
Q1 2023

May 15, 2023
SELL
$680.49 - $826.97 $46.7 Million - $56.7 Million
-68,587 Reduced 28.62%
171,099 $141 Million
Q4 2022

Feb 21, 2023
SELL
$705.89 - $766.39 $13.3 Million - $14.5 Million
-18,887 Reduced 7.3%
239,686 $173 Million
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $11.7 Million - $14.7 Million
-20,339 Reduced 7.29%
258,573 $178 Million
Q2 2022

Aug 15, 2022
SELL
$548.35 - $738.84 $2.96 Million - $3.99 Million
-5,396 Reduced 1.9%
278,912 $165 Million
Q1 2022

May 16, 2022
BUY
$595.12 - $698.43 $6.29 Million - $7.39 Million
10,575 Added 3.86%
284,308 $199 Million
Q4 2021

Feb 11, 2022
BUY
$543.48 - $670.97 $30.3 Million - $37.4 Million
55,802 Added 25.61%
273,733 $173 Million
Q3 2021

Nov 12, 2021
BUY
$574.03 - $680.96 $64.2 Million - $76.2 Million
111,854 Added 105.45%
217,931 $132 Million
Q2 2021

Aug 13, 2021
BUY
$472.8 - $558.54 $1.35 Million - $1.6 Million
2,865 Added 2.78%
106,077 $59.2 Million
Q1 2021

May 14, 2021
BUY
$446.73 - $548.2 $385,081 - $472,548
862 Added 0.84%
103,212 $48.8 Million
Q4 2020

Feb 16, 2021
BUY
$478.3 - $607.98 $1.99 Million - $2.53 Million
4,164 Added 4.24%
102,350 $49.4 Million
Q3 2020

Nov 13, 2020
BUY
$544.75 - $658.21 $2.37 Million - $2.87 Million
4,356 Added 4.64%
98,186 $55 Million
Q2 2020

Aug 11, 2020
BUY
$493.32 - $643.92 $5.02 Million - $6.55 Million
10,174 Added 12.16%
93,830 $58.5 Million
Q1 2020

May 15, 2020
SELL
$336.18 - $494.43 $7.25 Million - $10.7 Million
-21,574 Reduced 20.5%
83,656 $40.8 Million
Q4 2019

Feb 14, 2020
SELL
$274.13 - $376.51 $52,358 - $71,913
-191 Reduced 0.18%
105,230 $39.5 Million
Q3 2019

Nov 14, 2019
BUY
$273.46 - $318.39 $7.66 Million - $8.91 Million
28,000 Added 36.17%
105,421 $29.2 Million
Q2 2019

Aug 14, 2019
BUY
$299.6 - $414.82 $3.26 Million - $4.51 Million
10,877 Added 16.35%
77,421 $24.2 Million
Q1 2019

May 15, 2019
SELL
$372.08 - $439.57 $6.63 Million - $7.83 Million
-17,816 Reduced 21.12%
66,544 $27.3 Million
Q4 2018

Feb 15, 2019
BUY
$335.82 - $403.04 $4.71 Million - $5.65 Million
14,030 Added 19.95%
84,360 $31.5 Million
Q3 2018

Nov 15, 2018
BUY
$351.14 - $408.51 $979,680 - $1.14 Million
2,790 Added 4.13%
70,330 $28.4 Million
Q2 2018

Aug 14, 2018
BUY
$284.6 - $344.99 $1.59 Million - $1.93 Million
5,593 Added 9.03%
67,540 $23.3 Million
Q1 2018

May 11, 2018
BUY
$315.82 - $393.78 $2.47 Million - $3.08 Million
7,823 Added 14.45%
61,947 $21.3 Million
Q4 2017

Feb 15, 2018
BUY
$358.63 - $469.95 $9.82 Million - $12.9 Million
27,393 Added 102.48%
54,124 $20.1 Million
Q3 2017

Nov 08, 2017
BUY
$431.38 - $504.0 $11.5 Million - $13.5 Million
26,731
26,731 $12 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email